Axtria Ignite Webinar

Defining the Real ROI of Agentic and Generative AI | Ignite Webinar

Admin — Thu, 26 Mar 2026 06:40:11 GMT

Agentic and Generative AI are no longer experimental concepts. They are active investments reshaping how life sciences organizations operate. Yet as pilots scale and use cases expand, one question continues to surface at the executive level: Where is the measurable business value?

Smarter Field Engagement with Agentic AI | Axtria On-Demand Webinar

Admin — Thu, 27 Nov 2025 08:30:31 GMT

When field teams thrive, patients benefit. But today, many field reps and managers spend more time navigating disconnected systems, manual reports, and administrative tasks than engaging HCPs. This leads to missed opportunities, slower brand adoption, and growing frustration.

Reimagining Data Quality & Commercial Excellence with Agentic AI

Admin — Thu, 20 Nov 2025 10:00:59 GMT

Data quality challenges and reactive resolutions have long slowed commercial execution and brand performance, but Agentic AI is reimagining that landscape by making data quality management smarter, faster, proactive and self-learning. This session explores how Axtria’s Agentic Data Quality framework is transforming commercial data operations through intelligent anomaly detection, rule-based automation, and adaptive machine learning classification.

Always-On AI/ML: Driving Smarter Healthcare Decisions

Admin — Mon, 06 Oct 2025 06:20:59 GMT

The healthcare industry is undergoing rapid transformation, driven by evolving patient needs, technological advancements, and shifting market dynamics. In this fast-paced environment, understanding the key factors that influence brand performance is essential for ensuring the success of pharmaceutical products. However, brand teams often face significant delays in accessing these insights, with data arriving weeks or even months after critical decisions are made. This lag can hinder timely interventions and strategic pivots.

Harmonizing Pharma Strategy & Agility with Agentic AI

Admin — Thu, 28 Aug 2025 12:32:01 GMT

Pharmaceutical promotion plans have evolved from annual, static planning to a dynamic, always-on model that demands agile responses and continuous optimization. In this webinar, we explore the distinct but interconnected roles of long-term marketing mix modeling (MMX), mid-term dynamic omnichannel targeting, and short-term Next Best Action (NBA) strategies. Each approach brings its own measurement model and optimization needs—but true value lies in their working together seamlessly.

Accelerating Market Access with AI: Beyond Propensity Scores

Admin — Thu, 08 May 2025 13:06:05 GMT

In the pharmaceutical industry, the need for reliable evidence on the effectiveness of treatments is more critical than ever. While clinical trial results and statistical associations provide valuable insights, they aren’t always possible or don’t answer the most important question: What truly causes the observed outcomes? Whether it’s assessing the impact of a new drug outside of clinical trial populations, comparing outcomes across treatment strategies, or determining the long-term impact of a therapy, causal inference (CI) offers a precise framework for understanding cause-and-effect relationships and making informed decisions.

This webinar will explore how CI helps pharmaceutical researchers move beyond correlation to uncover the underlying mechanisms of drug efficacy, safety, and market performance. We’ll address how CI methods can be applied to both observational data and clinical trials, answering questions like: What happens if we change a treatment protocol? and What would the patient outcomes look like under different conditions?

We will also discuss the regulatory stance on CI in pharmaceutical research and its growing importance in drug development and approval. With a focus on real-world applications, you’ll learn how CI can help answer key business questions such as the comparative effectiveness of drugs, the impact of new treatments on real-world patient outcomes, and the economic benefits of alternative therapies.

In this webinar, Axtria will share perspectives covering:

Harnessing AI/ML for Pharma Forecasting: Insights & Innovations

Admin — Thu, 24 Apr 2025 11:45:16 GMT

Discover the transformative power of AI/ML in pharmaceutical forecasting by joining our upcoming webinar. Gain valuable insights to help you leverage AI/ML for more precise and actionable forecasting, driving better decision-making and operational efficiency:

Maximizing Commercial Performance with RWD & Clinical Data

Admin — Thu, 27 Mar 2025 16:33:36 GMT

Late-phase clinical trials, post-market studies, and patient registries represent more than regulatory obligations—they are strategic assets that can dramatically enhance a drug's commercial trajectory and market potential. This presentation explores how pharmaceutical companies can transform these studies from cost centers to value drivers by implementing a comprehensive, data-driven approach to commercial strategy.

Scaling Life Sciences Commercial Analytics with Data as a Product

Admin — Wed, 26 Feb 2025 21:01:15 GMT

A strong foundation in data and analytics is critical for the commercial function to stay competitive in the constantly evolving landscape. Along with the criticality of quality and trustworthy data, the number of functional use cases has grown rapidly. This webinar is a must for anyone looking to stay ahead in a competitive field by leveraging data as a product.

In this webinar, you will also learn:

Key Trends Transforming Pharma Commercial Model design for Success

Admin — Thu, 16 Jan 2025 18:13:10 GMT

The healthcare landscape continues to evolve. Consolidation is shifting the dynamics of influence in numerous ways in different parts of the country. We will examine the different ways pharmaceutical companies are approaching these new dynamics and evolving their commercial model design to maximize performance. These approaches include: